Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Thoracic Malignancy Steering Committee Roster

The Thoracic Malignancy Steering Committee (TMSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in chest malignancies. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The TMSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.

 

Co-chairs

David P. Carbone, M.D., Ph.D.
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Megan E. Daly, M.D.
University of California Davis Comprehensive Cancer Center
Sacramento, CA

Jessica Donington, M.D., M.S.C.R.
University of Chicago Medicine
Chicago, IL

 

Members

Upal Basu Roy, Ph.D., M.P.H.
LUNGevity Foundation
Bethesda, MD

Jeffrey A. Bogart, M.D.
State University of New York Upstate Medical University
Syracuse, NY

Penelope Bradbury, M.B. B.Ch., M.D., FRACP
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada

Jeffrey D. Bradley, M.D.
University of Pennsylvania Perelman School of Medicine 
Philadelphia, PA

Julie R. Brahmer, M.D.
Johns Hopkins University Sydney Kimmel Comprehensive Cancer Center
Baltimore, MD

Maximilian Diehn, M.D., Ph.D.
Stanford University
Stanford, CA

Martin J. Edelman, M.D.
Fox Chase Cancer Center
Philadelphia, PA

Justin Gainor, M.D.
Massachusetts General Hospital 
Boston, MA

Jhanelle E. Gray, M.D.
Moffitt Cancer Center
Tampa, FL

Stephen L. Graziano, M.D.
State University of New York Upstate Medical University
Syracuse, NY

Roy S. Herbst, M.D., Ph.D.
Yale University 
New Haven, CT

McGarry Houghton, M.D.
Fred Hutchinson Cancer Research Center
Seattle, WA

Puneeth Lyengar, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center 
New York, NY

Judith M. Johnson, M.B.A.
Patient Advocate 
St. Louis, MO

Edward L. Korn, Ph.D.
National Cancer Institute
Bethesda, MD

Shakun M. Malik, M.D.
National Cancer Institute
Bethesda, MD

Sumithra J. Mandrekar, Ph.D.
Mayo Clinic
Rochester, MN

Linda Martin, M.D., M.P.H., FACS
University of Virginia 
Charlottesville, VA

Margaret Mooney, M.D., M.B.A.
National Cancer Institute
Bethesda, MD

Kurt R. Oettel, M.D., M.B.A, FACP
Gundersen Health System
La Crosse, WI

Joseph Pater, M.D., FRCP
Queen's University
Kingston, ON, Canada

Mary W. Redman, Ph.D.
Fred Hutchinson Cancer Research Center
Seattle, WA

Amy N. Sanford, M.D.
University of South Dakota School of Medicine
Sioux Falls, SD

David S. Schrump, M.D.
National Cancer Institute
Bethesda, MD

Lecia Sequist, M.D.
Massachusetts General Hospital
Boston, MA

Thomas E. Stinchcombe, M.D.
Duke University School of Medicine
Durham, NC

NCI CCCT Program Director

Mehrdad Mohseni, M.D.
mehrdad.mohseni@nih.gov

 

  • Updated:
Email